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Under physiological conditions, interaction between ceftriaxone and human serum albumin was 
investigated by using fluorescence spectroscopy and ultra violet (UV) absorption spectrum. From 
spectral analysis, ceftriaxone showed a strong ability to quench the intrinsic fluorescence of human 
serum albumin (HSA) through a static quenching procedure. The binding constant (k) is estimated as 
K=1.02× 10
3
 M
-1
 at 298 K. Fourier transform infrared spectroscopy (FT-IR) spectroscopy with Fourier 
self-deconvolution technique was used to determine the protein secondary structure and drug binding 
mechanisms. The observed spectral changes indicated the formation of H-bonding between ceftriaxone 
and HSA molecules at higher percentage for -helix than for the -sheets. 
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INTRODUCTION 
 
In recent years, many  investigations on the  binding  of  
drugs and natural  products  to  human serum albumin 
(HSA) were carried out (Il’ichev et al., 2002; Qing et al., 
2011; Ahmad et al., 2006; Liu et al., 2009). Ceftriaxone, 
as a possible ligand, was not studied in details upon its 
binding reaction with HSA. It has been reported that 
Ceftriaxone binds to HSA (Guowen et al., 2011, Bibiana 
et al., 1996).  
Ceftriaxone, a cephalosporin, is bound reversibly to 
defatted human serum albumin from adults, with a first 
stoichiometric binding constant of 6x10
4
 M
-1
, as found by 
equilibrium dialysis at pH 7.4, 37C (Roberton et al., 
1989). So far, none of the investigations determine in 
details the Ceftriaxone-HSA binding  constant  and  the  
effects of  Ceftriaxone  complexation  on  the  protein.  
Ceftriaxone belongs to a group of antibiotics called the 
cephalosporins. It is a parenteral cephalosporin that dis-
plays a broad spectrum of activity against Gram-negative 
and Gram-positive pathogens; its chemical structure is 
shown in Figure 1 (Bilirubin et al., 1989). Ceftriaxone is 
indicated for a wide variety of infections. These include 
infections of the lower respiratory and urinary tracts, bac-
terial septicemia, skin and skin structure infections, bone 
and joint infections, pelvic inflammatory disease, uncom-
plicated gonorrhea, intra-abdominal infections, acute bac-
terial otitis media, meningitis, as well as surgical 
prophylaxis (Quaglia et al., 1997). 
The drug is widely used because of its broad spectrum 
of antibacterial activity, infrequent side-effects, and long 
serum half-life and it has recently been recommended as 
the drug of choice for use in newborn infants exposed to 
Neisseria gonorrhea during delivery (Bibiana et al., 
1996).  
It has been reported that ceftriaxone is transported 
through the blood-brain barrier (Scott et al., 2008; 
Reynold et al., 1987) and it is widely accepted that some 
conformational diseases, such as Alzheimer’s and prion 
diseases can be the result of misfolding due to lack of 
stability in parallel β-sheets (Locht et al., 1990). Recent 
reports suggest that somedrugs may accelerate these
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Figure 1. Chemical structure of ceftriaxone. 
 
 
 
neurodegenerative diseases (Rabia et al., 2009). This 
emphasizes the needs to understand protein folding and 
sheets stability in some proteins complexes with drugs. 
The widespread use of ceftriaxone and its transport 
through the blood-brain barrier makes it necessary to 
study structural changes of ceftriaxone -protein com-
plexes to understand the biological effects and functions 
of ceftriaxone in the body. Thus, the study of ceftriaxone -
protein interaction is of great interest in the field of 
biophysics, life sciences and clinical medicine. 
HSA is the most abundant protein in human plasma, 
which is synthesized in the liver (Fengling et al., 2006) 
and is able to bind and thereby transport various com-
pounds such as fatty acids, hormones, bilirubin, trypto-
phan, steroids, metal ions, therapeutic agents and a large 
number of drugs. HSA serves as the major soluble pro-
tein constituent of the circularity system, it contributes to 
colloid osmotic blood pressure, it can bind and carry 
drugs which are mainly poorly soluble in water (Peters et 
al., 1985). HSA accounts for approximately 60% of the 
total plasma protein corresponding to a concentration of 
40 mg/ml in the blood (~0.6 mM) (Peters et al., 1985).  
The three dimensional structure of HSA was determined 
through x-ray crystallographic measurements (He et al., 
1992). This globular protein consists of a single poly-
peptide chain of 585 amino acids (Hal et al., 2000), which 
have a molecular weight of 66 kDa (Bian et al., 2004). 
HSA composed of three homologous domains I, II and III, 
each containing two sub-domains, A and B, each having 
six and four α-helices, respectively (Curry et al., 1999). 
The tertiary structure of HSA is stabilized by 17 disul-
phide bridges giving it a heart shaped molecule (He et al., 
1992; Bian et al., 2004). 
It has been shown that distribution, free concentration, 
and metabolism of various drugs can be significantly 
altered as a result of their binding to HSA (Artali et.al, 
2005; Kang et al., 2004). The binding properties of albu-
min depend on the three dimensional structure of the 
binding sites, which are distributed all over the molecule. 
Strong binding can decrease the concentrations of free 
drugs in plasma, whereas weak binding can lead to a 
short lifetime or poor distribution or both. Its remarkable 
capacity to bind a variety of drugs results in its prevailing 
role in drug pharmacokinetics and pharmacodynamics 
(Kandagal et.al, 2007). 
Multiple drug binding sites have been reported for HSA 
by several groups of researchers (Bhattacharyya
 
et al, 
2006; Simard et al., 2006; Ulrich .et al., 2006). The 
principal regions of ligand binding sites of HSA are 
located in hydrophobic cavities in sub domains IIA and 
IIIA, which corresponds to site I and site II, respectively. 
Site I is dominated by strong hydrophobic interaction with 
most neutral, bulky, heterocyclic compounds, while site II 
mainly by dipole-dipole, van der Waals, and/or hydrogen-
bonding interactions with many aromatic carbo-xylic 
acids. HSA contained a single tryptophan residue (Trp-
214) in domain IIA and its intrinsic fluorescence is 
sensitive to the ligands bound nearby (Krishnakumar et 
al., 2002; Muravchick et al., 1995). Therefore, it is often 
used as a probe to investigate the binding properties of 
drugs with HSA. 
The interaction of ceftriaxone sodium (CS), a cephalo-
sporin antibiotic, with the major transport protein, bovine 
serum albumin (BSA), was investigated using different 
spectroscopic techniques such as fluorescence, circular 
dichroism (CD), and UV-vis spectroscopy (Cao et al., 
2012). The mechanism of the interaction between bovine 
serum albumin (BSA) and ceftriaxone with and without 
zinc (II) (Zn
2+
) was studied employing fluorescence, 
ultraviolet (UV) absorption, circular dichroism (CD), and 
synchronous fluorescence spectral methods. The intrinsic 
fluorescence of BSA was quenched by ceftriaxone in a 
static quenching mode, which was authenticated by 
Stern-Volmer calculations.  
The binding constant, the number of binding sites, and 
the thermodynamic parameters were obtained, which indi-
cated a spontaneous and hydrophobic interaction bet-
ween BSA and ceftriaxone regardless  of Zn
2+
  (Liu  et al., 
 
 
 
 
2012).   
In this study, we have investigated the interaction of 
ceftriaxone with HSA by means of FT-IR, UV/VIS, and 
fluorescence spectrophotometer. Infrared spectroscopy 
provides measurements of molecular vibrations due to 
the specific absorption of infrared radiation by chemical 
bonds. It is known that the form and frequency of the 
Amide I band, which is assigned to the C=O stretch-ing 
vibration within the peptide bonds is very characteristic 
for the structure of the studied protein.  
From the band secondary structure, components peaks 
(α-helix, β-strand) can be derived and the analysis of this 
single band allows elucidation of conformational changes 
with high sensitivity (Abu et al., 2011). This work will be 
limited to the mid-range infrared, which covers the 
frequency range from 4000 to 400 cm
-1
. This wavelength 
region includes bands that arise from three 
conformational sensitive vibrations within the peptide 
backbone (Amides I, II and III) of these vibrations. Amide 
I is the most widely used and can provide information on 
secondary structure composition and structural stability 
(Cui et al., 2008; Kang et al., 2004; Rondeau et al., 
2007).  
One of the advantages of infrared spectroscopy is that 
it can be used with proteins that are either in solution or 
in thin film. In addition there is a growing body of 
literature on the use of infrared to follow reaction kinetics 
and ligand binding in proteins, as will as a number of 
infrared studies on protein dynamics.  
The identification of the binding sites in albumin was 
also performed using probes for the so-called sites I, II, 
bilirubin and fatty acids binding sites. Albumin showed 
two types of binding sites for cefoperazone and ceftria-
xone, while for cefsulodin it showed a single type of bind-
ing site (Pico et al., 1996). 
The mechanism of the interaction between human 
serum albumin (HSA) and ceftriaxone has been studied 
by using UV, fluorescence and FTIR spectroscopy. Further-
more temperature dependent conformation of HSA struc-
ture at different concentrations of Ceftriaxone has been 
studied by FT-IR spectroscopy.  
 
 
MATERIALS AND METHODS 
 
Human serum albumin (HSA, 96-99% purity) and Ceftriaxone 
disodium salt hemi(heptahydrate)  in  powder  form  were  pur-
chased  from  Sigma  Aldrich  chemical  company and used without 
further purification. 
 
 
Preparation of stock solutions 
 
HSA  was  dissolved  in  phosphate  buffer  saline,  at  physiological  
pH  7.4 at  (80 mg/ml) concentration. Ceftriaxone with molecular 
weight of 66.5 kDa was dissolved in phosphate buffer saline (1.21 
mg/ml), the solution was placed in ultrasonic water path (SIBATA 
AU-3T) for   6 h to ensure that all the amount of Ceftriaxone was 
completely dissolved.  The final concentrations of HSA- Ceftriaxone 
complexes were prepared by mixing equal volume of HSA and 
Ceftriaxone  stock solution. HSA  concentration in  all samples were 
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fixed at 40 mg/ml (~0.6 mM). However, the concentration of 
Ceftriaxone in the final protein drug solutions was decreased 
gradually to attain the desired drug concentrations of 0.687, 0.910, 
1.14, 1.37, 1.60, 1.83 and 2.06 mM. The solution of Ceftriaxone and 
HSA were incubated for 1 h (at 25C) before spectro-scopic 
measurements were taken. 
 
 
Fluorescence 
 
The ﬂuorescence measurements were performed by a Nano-Drop 
ND-3300 Fluorospectrometer at 25C. The excitation had been 
done at the wavelength of 360 nm and the maximum emission 
wavelength was at 439 nm. The excitation source comes from one 
of three solid-state light emitting diodes (LED’s). The excitation 
source options include: UV LED with maximum excitation of 365 
nm, Blue LED with excitation of 470 nm, and white LED from 500 to 
650 nm excitation. A 2048-element CCD array detector covering 
400-750 nm, was connected by an optical fiber to the optical 
measurement surface. The emission spectra were recorded for free 
HSA 40 mg/ml (~0.6 mM) and for its complexes with ceftriaxone 
solutions with the concentrations of (0.687, 0.910, 1.14, 1.37, 1.60, 
1.83, 2.06 mM). Repeated measurements were done for all 
samples and no significant differences were observed. 
 
 
FT-IR spectroscopy experimental procedures 
 
The FT-IR measurements were obtained on a Bruker IFS 66/S 
spectrophotometer equipped with a liquid nitrogen-cooled MCT 
detector and a KBr beam splitter. The spectrometer was conti-
nuously purged with dry air during the measurements. The 
absorption spectra were obtained in the wave number range of 400-
4000 cm-1. A spectrum was taken as an average of 60 scans to 
increase the signal to noise ratio, and the spectral resolution was at 
4 cm-1. The aperture used in this study was 8 mm, since we found 
that this aperture gives best signal to noise ratio. Baseline 
correction, normalization and peak areas calculations were per-
formed for all the spectra by OPUS software. The peak positions 
were determined using the second derivative of the spectra. The 
infrared spectra of HSA, and Ceftriaxone-HSA complex were 
obtained in the region of 1000-1800 cm−1. The FT-IR spectrum of 
free HSA was acquired by subtracting the absorption spectrum of 
the buffer solution from the spectrum of the protein solution. For the 
net interaction effect, the difference spectra [(protein and 
Ceftriaxone solution) - (protein solution)] were generated using the 
featureless region of the protein solution 1800-2200 cm-1 as an 
internal standard (Surewicz et al., 1993). The accuracy of this 
subtraction method is tested using several control samples with the 
same protein or drug concentrations, which resulted into a flat base 
line formation. The obtained spectral differences were used here, to 
investigate the nature of the drug-HSA interaction. We had also 
used ELAB 12/05 thermo system to directly and simultaneously 
determine the thermo-dependent structural changes of drug-protein 
complexes. 
 
 
RESULTS AND DISCUSSION 
 
Analysis of ﬂuorescence quenching of HSA by 
Ceftriaxone 
 
Fluorescence spectroscopy is one of the most widely 
used spectroscopic techniques in the fields of bioche-
mistry and molecular biophysics today (Royer et al., 
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Figure 2. Fluorescence emission spectra of HSA in the absence and presence of ceftriaxone at 
different concentrations. 
 
 
 
1995). Fluorescence measurements can give some 
information on the binding mechanism of small molecule 
substances to protein, including binding mode, binding 
constants, binding sites and intermolecular distances (Liu 
et al., 2004). The fluorescence of HSA comes from 
tryptophan, tyrosine and phenylalanine residues.  
Actually, the intrinsic fluorescence of HSA is almost 
contributed by tryptophan alone (Sulkowska et al., 2002). 
Figure 2 shows the ﬂuorescence spectra of HSA in the 
presence of various concentrations of ceftriaxone. It is 
obvious that HSA ﬂuorescence intensity gradually 
decreased with the increase of Ceftriaxone concentration, 
while the peak position shows little or no change upon 
increasing the concentration of Ceftriaxone to HSA, 
indicating that Ceftriaxone binds to HSA. Under the same 
condition, no fluorescence of  Ceftriaxone  was  observed 
hich  indicates  that Ceftriaxone  could  quench  the  auto 
fluorescence  of  HSA which confirm that Ceftriaxone 
interacts with HSA, leading to a change in the 
microenvironment around the tryptophan residue 
exposing it to the polar solvent (Wang et al., 2007; Cui et 
al., 2007). 
Two mechanisms, namely dynamic quenching and 
static quenching are responsible for the ﬂuorescence 
quenching. The possible quenching mechanism can be 
deduced from the Stern-Volmer plot. The dynamic 
quenching process can be described by the Stern-Volmer 
equation (Tian et al., 2003) 
 
                                  (1) 
 
Where, F0 and F are the ﬂuorescence intensities of HSA 
in the absence and presence of the quencher, 
respectively. Kq is the quenching rate constant of the 
biomolecule, KSV is the Stern-Volmer dynamic quenching 
constant, and KSV=Kqτ0. τ0 is the average lifetime of the 
biomolecule without quencher. The value of τ0 of the 
biopolymer was 10
-8
s
-1 
(Chen et al., 1990), and [Q] is the 
concentration of quencher ceftriaxone. 
The Stern-Volmer quenching constant Ksv indicates 
the sensitivity of the fluorophore to a quencher. Linear 
curves were plotted according to the Stern-Volmer 
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Figure 3. The Stern-Volmer plot for Ceftriaxone-HSA complexes. 
 
 
 
equation as shown in Figure 3 for ceftriaxone- HSA 
complexes. The Stern-Volmer quenching constant Ksv 
was obtained by the slope of the curve obtained in Figure 
3, and its value equals 8.92×10
2
 L mol
-1
. 
From the equation above, the value of Ksv=Kqτ0, can 
be used to calculate the value of Kq using the 
fluorescence life time of 10
-8
 s for HSA, to obtain Kq 
value of (8.92×10
10
 L mol
-1
s
-1
) for ceftriaxone- HSA 
complexes. Generally, the maximum dynamic quenching 
constant, Kq of various kinds of quenchers with 
biopolymer was 2.0×10
10
 L mol
-1
s
-1
 (Lakowicz et al., 
1973).  
Obviously, the values of kq were greater than that of 
the maximum dynamic quenching constant. This sug-
gested that the ﬂuorescence quenching was not the 
result of dynamic quenching, but the consequence of 
static quenching (Chen et al., 1990, Wang et al., 2008). 
When static quenching is dominant, the modified Stern-
Volmer equation could be used (Lakowicz, et al.1999). 
 
                                                        (2) 
 
Where, K is the binding constant of ceftriaxone with HSA, 
and can be calculated by plotting 1/(F0-F) vs. 1/L (Figure 
4). The value of K was obtained from the values of slope 
and intercept, respectively. K equals the ratio of the 
intercept to the slope.  
The value of K was 1.02×10
3
 M
-1
 at room temperature, 
which is consistent with the value obtained by Bibiana et 
al., (1996) and Patrick et al. (1990). In vitro protein 
binding studies were conducted to examine the 
interaction between ceftriaxone (CEF), probenecid 
(PROB) and diazepam (DIAZ). The presence of PROB 
and DIAZ at concentrations equal to molar albumin 
concentration caused a decrease in CEF affinity from 3.7 
x 10
4
 M
-1
 (control) to 1.1 x 10
4
 (PROB) and 2.6 x 10
4
 
(DIAZ) M
-1
, but not in binding capacity in pooled human 
plasma ( Stoeckel et al., 1990). 
The value obtained is indicative of a weak Ceftriaxone-
HSA interaction with respect to the other drug-HSA 
complexes with binding constants in the range of 10
5
 and 
10
6
 M
-1
 (Kragh-Hansen et al., 1981). The highly effective 
quenching constant in this case has lead to a lower value 
of binding constant between the drug and HSA due to an 
effective hydrogen bonding between ceftriaxone and 
HSA. 
 
 
FT-IR spectroscopy 
 
FT-IR spectroscopy is a powerful technique for the study 
of hydrogen bonding (Li et al., 2006), and has been iden-
tified as one of the few techniques that is established
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Figure 4. The plot of 1/(Fo-F) vs (1/L) for ceftriaxone- HSA complexes. 
 
 
 
in the determination of protein secondary structure at 
different physiological systems (Sirotkin et al., 2001; 
Arrondo et al., 1993). The information on the secondary 
structure  of  proteins  could be deduced from the infrared 
spectra. Proteins exhibit a number of amide bands, which 
represent different vibrations of the peptide moiety. The 
amide group of proteins and polypeptides presents charac-
teristic vibrational modes (amide modes) that are sen-
sitive to the protein conformation and largely been con-
strained to group frequency interpretations (Ganim et al., 
2006).  
The modes most widely used in protein structural 
studies are amide I, amide II and amide III. Amide I band 
ranging from 1700 to 1600 cm
-1
 and arises principally 
from the C=O stretching (Vandenbussche G et al., 1992), 
has been widely accepted to be used (Workman et al., 
1998). The amide II band is primarily N-H bending with a 
contribution  from C-N  stretching vibrations; amide  II  
ranging  from  1600  to  1480  cm
-1 
while  amide  III  band  
ranging from 1330 to 1220 cm
-1
 which is due to the C-N  
stretching mode coupled  to  the  in-plane N - H bending  
mode (Arrondo et al., 1993; Jackson et al., 1991). 
The second derivative of free HSA is shown in Figure 
5A, where the  spectra  is  dominated  by  absorbance 
bands of amide I and amide II at peak positions 1656 and  
154 4cm
-1
, respectively. Figure 5B, shows the spectrum 
of ceftriaxone- HSA complexes with different 
concentrations of ceftriaxone. 
The peak positions of amide I bands in HSA infrared 
spectrum shifted as listed in Table 1: 1637-1642 cm
-1
, 
1655-1658 cm
-1
, 1683-1679 cm
-1
, 1693-1692 cm
-1
 after 
interaction with ceftriaxone. In addition, peaks at 1613 
and 1626 cm
-1
 had disappeared and also a new peak at 
1663 cm-1 had appeared after the interaction of 
ceftriaxone with HSA. In amide II, the peak positions 
have shifted as follows:  1496 to 1494 cm
-1
, 1512 to 1513 
cm
-1
, 1544 to 1536 cm
-1
 and 1580 to 1584 cm
-1
. In 
addition, a new peaks at 1552 and 1568 cm
-1
 appeared 
after the interaction of ceftriaxone with HSA. In the Amide 
III region little or no change of the peak positions has 
been observed. The changes of these peak positions and 
peak shapes implied that the secondary structures of 
HSA had been changed by the interaction of ceftriaxone 
with HSA. The minor changes in peak positions can be 
attributed to the effect of the newly formal H-bonding 
between ceftriaxone molecules with the protein. It is 
suggested that, the shift to a higher frequency for the 
major peak in amide I region (1656-1658 cm
-1
)  came  as  
a  result  of  stabilization  by hydrogen  bonding  by  ha-
ving  the  C-N  bond  assuming partial double bond cha-
racter due  to a low of electrons from the C=O to the C-N 
bond (Jackson et al., 1991). 
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Figure 5. The spectra of (A) HSA free (second derivative) and (a, b, c, d, e, and f) HSA-Ceftriaxone IR 
absorption spectrum with Ceftriaxone concentrations (0.0, 0.687, 0.910, 1.14, 1.37, and 1.60 mM) 
respectively. 
 
 
 
Determination of the secondary structure of HSA and 
its ceftriaxone complexes was carried out on the basis of 
the procedure described by Byler et al. (1986).  In this 
work, a quantitative analysis of the protein secondary struc-
ture for the free HSA and ceftriaxone- HSA complexes in 
dehydrated films is determined from the shape of amides
8          J. Biophys. Struct. Biol. 
 
 
 
Table 1. Band assignment in the absorption spectra of HSA with different ceftriaxone concentrations for amide I, II and III 
regions. 
 
    Bands  
HSA 
Free 
HSA-Ceft. 
0.687mM 
HSA-Ceft. 
0.910 mM 
HSA-Ceft. 
1.14 mM 
HSA-Ceft. 
1.37 mM 
HSA-Ceft. 
1.60 mM 
Amide I (1610-1700 cm
-1
)
 
 
1613 
1626 
1637 
1655 
 
1683 
1693 
 
1627 
1641 
1654 
1662 
1680 
1693  
 
1625 
1641 
1655 
1662 
1679 
1693  
 
1629 
1642 
1656 
1662 
1679 
1692 
 
 
1642 
1657 
1662 
1678 
1692  
 
 
1642 
1658 
1663 
1679 
1692 
Amide II (1480-1600  cm
-1
) 
1496 
1512 
1544 
 
 
1580  
1497 
1513 
1545 
1552 
1569 
1586  
1498 
1513 
1546 
1551 
1568 
1585  
1498 
1514 
1536 
1551 
1568 
1585  
1499 
1514 
1535 
1551 
1568 
1586  
1494 
1513 
1536 
1552 
1568 
1584 
Amide III (1220-1330 cm
-1
) 
1242 
1263 
1303 
1313 
1242 
1263 
1288 
1312  
1242 
1264 
1288 
1312  
1242 
1261 
1288 
1311  
1241 
1261 
1288 
1311  
1241 
1260 
1288 
1312  
 
 
 
I, II and III bands. Infrared Fourier self-deconvolution with 
second derivative resolution and curve fitting procedures, 
were applied to increase spectral resolution and therefore 
to estimate the number, position and area of each 
component bands. The procedure was in general carried 
out considering only components detected by second 
derivatives and the half widths at half height (HWHH) for 
the component peaks are kept around 5 cm
-1
; the above 
procedure was reported in our recent publications (Abu et 
al., 2011; Darwish et al., 2010; Abu et al., 2012). 
The component bands of amides I, II, and III regions 
were assigned to a secondary structure accor-ding to the 
frequency of its maximum raised after Fourier self 
deconvolution have been applied for amide I band 
ranging from 1610 to 1700 cm
-1
 generally assigned as 
follows: 1610-1627 cm
-1
 are generally represented to 
parallel β-sheet, 1627-1643 cm
-1
 represent random coil, 
1643-1672 cm
-1
 represent α-helix, 1672-1787 cm
-1
 
represent turn structure, and 1687-1700 cm
-1
 represent β-
antiparallel. For amide II ranging from 1480 to 1600 cm
-1
, 
the absorption band was assigned in the following order: 
1485-1502 cm
-1
 represent parallel β-sheet, 1502-1529 
cm
-1
 represent random coil, 1529-1563 cm
-1
 represent α-
helix, 1563-1587 cm
-1
 represent turn structure, and 1587- 
1600 cm
-1
 represent β-antiparallel.  
For amide III ranging from 1220 to 1330 cm
-1
 was 
assigned as follows: 1220-1255 cm
-1
 represent parallel β-
sheet, 1255-1301 cm
-1
 represent random coil, 1301-1317 
cm
-1
 represent turn structure, and 1317-1330 cm
-1
 repre-
sent α-helix. Most investigations have concentrated on 
Amide I band assuming higher sensitivity to the change 
of protein secondary structure (Vass et al., 1997). How-
ever, it has been reported that amide II and amide III 
bands have high information content and could be used 
for prediction of proteins secondary structure (Oberg et 
al., 2004, Jiang et al., 2004, Liu et al., 2003). 
Based on the above assignments, the percentages of 
each secondary structure of HSA were calculated from 
the integrated areas of the component bands in amide I, 
amide II and amid III, respectively. Table 2 shows the 
content of each secondary structure of HSA before and 
after the interaction with ceftriaxone at different concen-
trations. The percentage values for the components of 
amide I of free HSA are consistent with the results of 
other recent spectroscopic studies.  
Figure 6 illustrates the variation of relative intensities 
with concentration change for the α-helix, parallel and 
antiparallel -sheets in HSA free and ceftriaxone-HSA 
complexes. The results exhibited a reduction of α-helical 
structures so that of amide II and amide III showed 
similar trends in their percentage values to that of amide I.  
The decrease of α-helix percentage with the increase of 
ceftriaxone concentrations is evident in the calculations 
and this trend is consistent in the three Amide regions. 
However, for the parallel and antiparallel β-sheet, relative 
percentage increased with increasing ceftriaxone 
concentrations and the relative intensity increased for the 
antiparallel β-sheets remarkably having a faster rate 
increase than the parallel β-sheets. 
The reduction of α-helix intensity percentage in favor of 
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Table 2. Secondary structure determination for amide I, II and III regions for HSA and its ceftriaxone complexes. 
 
Band  
HSA 
Free 
HSA-Ceft. 
0.687 mM 
HSA-Ceft. 
0.910 mM 
HSA-Ceft. 
1.14 mM 
HSA-Ceft. 
1.37 mM 
HSA-Ceft. 
1.60 mM 
Amide I       
Β-sheet parallel  (1610-1627 cm
-1
)  10 11 12 13 14 16 
Random (1627-1643 cm
-1
) 11 5 4 5 5 7 
α-helix (1643-1672 cm
-1
) 68 62 60 45 39 27 
Turns (1672-1687 cm
-1
) 8 16 16 24 25 32 
Β-sheet Anti-parallel (1687-1700 cm
-1
)  3 7 8 13 18 20 
Amide II       
 Β-sheet parallel (1485-1502 cm
-1
)  8 22 24 23 29 33 
 Random (1502-1529 cm
-1
) 27 9 6 9 4 2 
 α-helix (1529-1563 cm
-1
) 52 55 55 52 46 43 
 Turns (1563-1587 cm
-1
) 13 14 13 13 13 14 
 Β-sheet Anti-parallel (1587-1600 cm
-1
)  1 2 3 4 7 9 
Amide III       
 Β-sheet (1220-1255 cm
-1
) 30 20 14 16 14 12 
 Random (1255-1301 cm
-1
) 19 20 21 20 21 22 
 Turns (1301-1317 cm
-1
) 29 36 41 41 47 49 
 α-helix (1317-1330 cm
-1
) 23 25 24 23 19 17 
 
 
 
 
 
Figure 6. Relative intensities of HSA secondary-structure Amide I 
components as a function of increasing ceftriaxone concentration. 
The isolated symbols on the right correspond to the respective 
secondary structure components. 
 
 
 
the increase of β-sheets are believed to be due to the 
unfolding of the protein in the presence of ceftrixone as a  
result of the formation of H bonding between HSA and 
the antibiotic. The newly formed H-bonding result in the 
C-N bond assuming partial double bond character due to 
a flow of electrons from the C=O to the C-N bond which 
decreases the intensity of the original vibrations (Krimm 
et al., 1986); the hydrogen bonds in α-helix are formed 
inside the helix and parallel to the helix axis, while for β-
sheet, the hydrogen bonds take position in the planes of 
β-sheets as the preferred orientations especially in the 
anti-parallel sheets, so the restrictions on the formation of 
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Figure 7. Relative intensities of HSA secondary-structure components at different 
concentrations ceftriaxone as a function of increasing temperatures. The isolated symbols 
on the left correspond to the respective secondary structure components. 
 
 
 
hydrogen bonds in β-sheet relative to the case in α-helix 
explains the larger effect on reducing the intensity 
percentage of α-helix to that of β-sheet. Similar confor-
mational transitions from an α-helix to β-sheet structures 
were observed for the protein unfolding upon protonation 
and heat denaturation (Surewicz et al., 1987; Holzbaur et 
al., 1996). 
The variation of intensities with temperature change for 
α-helix, parallel and antiparallel -sheets in ceftriaxone-
HSA complexes are shown in Figure 7. The relative 
intensity increases as -temperature and ceftriaxone 
concentration increases- for the antiparallel β-sheets 
while it remarkably decreases for α-helix and the rate of 
increase for antiparallel β-sheets remarkably faster than 
the parallel β-sheets. The difference in behavior for the 
two types of β-sheets can be explained by the different 
amino acids and their preferred secondary structural 
arrangements in these -sheets. It has been reported, 
that the two forms of -sheets have different thermo-
dynamic propensities scale (Kim et al., 1993).  
The slight gradual increase in intensity of the parallel -
sheets is believed to be mainly due to the unfolding of the 
protein as a result of the formation of H-bonding between 
HSA and ceftriaxone. The newly formed H-bonding result 
in the C-N bond assuming partial double bond character 
due to electrons flow from the C=O to the C-N bond 
which decreases the intensity of the molecular vibrations 
(Fabian et al., 1993).  
On the other hand, an increase of intensity implies 
more stability and less conversions of the C=O bond as a 
result of the interaction with ceftriaxone. The parallel 
arrangement is less stable because the geometry of the 
individual amino acid molecules forces the hydrogen 
bonds to occur at an angle, making them longer and thus 
weaker.  
Contrarily, in the anti-parallel arrangement, the hydro-
gen bonds are aligned directly opposite to each other, 
making stronger and more stable bonds. 
 
 
Conclusion 
 
The binding of ceftriaxone to HSA has been investigated
by fluorescence spectroscopy and by FTIR spectroscopy.  
From the fluorescence study, we determined values for 
the binding constant and the quenching constant for 
ceftriaxone-HSA complexes. The results indicate that the 
intrinsic fluorescence of HSA was quenched by ceftria-
xone through static quenching mechanism. Analysis of 
the FTIR spectra reveals that HSA-ceftriaxone interaction 
results in major protein secondary structural changes in 
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the compositions of α-helix to that of the β-sheets. 
The obtained data show an increase in the intensity of 
the absorption band of the antiparallel sheets as tem-
perature increases. Higher concentrations of ceftriaxone 
provide an increase of the absorption band intensity for 
both the antiparallel and parallel -sheets.  
The intensity analysis is in support of higher stability for 
the anti-parallel -sheets compared to that of parallel β-
sheets. These variations in behavior are mainly due to 
the differences in the intrinsic properties of parallel and 
antiparallel-β sheets. More experimental studies are 
needed to determine the degree of stability of β-sheets 
and how does it affect protein folding.  
 
 
ACKNOWLEDGEMENT 
 
This work was supported by the German Research 
Foundation DFG Grant No. DR228/24-2. 
 
 
REFERENCES 
 
Abu Teir MM, Ghithan SJH, Darwish S, Abu-Hadid MM (2011). “Study 
of Progesterone interaction with Human Serum Albumin: 
Spectroscopic Approach,” J. Appl. Biol. Sci. 5 (13):35-47. 
Abu Teir MM, Ghithan SJH, Darwish S, Abu-hadid MM (2012). Multi-
spectroscopic investigation of the interactions between cholesterol 
and human serum albumin. J. Appl. Biol. Sci. 6(3):45-55. 
Ahmad B, Parveen S, Khan RH (2006). Effect of albumin conformation 
on the binding of ciprofloxacin to human serum albumin. 
Biomacromolecules 7:1350-1356. 
Arrondo JL, Muga A (1993). Quantitative studies of the structure of 
proteins in solution by Fourier-transform infrared spectroscopy. Prog. 
Biophys. Mol. Biol. 59:23-56. 
Artali R, Bombieri G, Calabi L, Del Pra A (2005). A molecular dynamics 
of human serum albumin binding sites. Il Farmaco 60:485-495. 
Bian Q, Xu LC, Wang SL, Xia YK, Tan LF, Chen JF, Song L, Chang 
HC, Wang XR (2004). Study on the relation between occupational 
fenvalerate exposure and spermatozoa DNA damage of pesticide 
factory workers. Occup. Environ. Med. 61:999-1005. 
Bibiana N, Beatriz Farruggia, Guillermo Pico (1996). A Comparative 
study of the binding characteristics of ceftriaxone, cefoperazone and 
cefsudolin to human serum albumin. Biochem. Mol. Biol. Int. 
40(4):823-831. 
Bilirubin RB, Alex R (1989). Ceftriaxone binding to human serum 
albumin. Mol. Pharmacol. 36:478-483. 
Brodersen R, Robertson A (1989). Ceftriaxone binding to human serum 
albumin: competition with birirubin. Mol. Pharnmacol. 36: 478-483. 
Byler M and Susi H (1986). Examination of the secondary structure of 
proteins by deconvolved FTIR spectra. Biopolymers. 25:469-487. 
Chen GZ, Huang XZ, Xu JG, Zheng ZZ, Wang ZB (1990). Method of 
Fluorescence Analysis, Science Press, Beijing,. 112-119. 
Cui F, Qin L, Zhang G, Liu X, Yao X, Lei B (2008). A concise approach 
to   1,11-didechloro-6-methyl-40-O-demethyl   rebeccamycin  and   its 
binding to human serum albumin: Fluorescence spectroscopy and 
molecular modeling method. Bioorg. Med. Chem.16:7615-7621. 
Cui F, Wang J, Cui Y, Yao X, Qu G, Lu Y (2007). Investigation of 
interaction between human serum albumin and N6-(2-hydroxyethyl) 
adenosine by fluorescence spectroscopy and molecular modelling. 
Luminescence. 22:546-553. 
Curry S, Brick P, Franks NP (1999). Fatty acid binding to human serum 
albumin: new insights from crystallographic studies. Biochem. 
Biophys. Acta 1441:131-140. 
Darwish SM, Abu sharkh SE, Abu Teir MM, Makharza SA, Abu hadid 
MM (2010). Spectroscopic investigations of pentobarbital interaction 
Abu Teir et al.          11 
 
 
 
with human serum albumin. J. Molecular Structure. 963:122-129. 
Fabian H, Schultz C, Naumann D, Landt O, Hahn U, Saenger WJ 
(1993). Secondary Structure and temperature-induced unfolding and 
refolding of ribonuclease T1 in aqueous solution: A Fourier transform  
infrared spectroscopic study. Mol. Biol. 232:967-981. 
Ganim Z, Tokmakoff  A (2006). Spectral Signatures of Heterogeneous 
Protein Ensembles Revealed by MD Simulations of 2DIR Spectra. 
Biophys. J. 91 : 2636. 
Guowen Zhang N, Nan Z, Lin W (2011). Probing the binding of vitexin to 
human serum albumin by multi spectroscopic techniques. J. Lumin 
131:880-887. 
Hal CP, Thomas PA, Ronald AH, Bliss SP (2000). Simmondsin and wax 
ester levels in 100 high-yielding jojoba clones. Industrial Crops Prod. 
12:151-157. 
He XM, Carter DC (1992). Atomic structure and chemistry of human 
serum albumin. Nature 358:209-215. 
Holzbaur IE, English AM, Ismail AA (1996). FTIR study of the thermal 
denaturation of horseradish and cytochrome c peroxidases in D2O. 
Biochemistry 35:5488-5494. 
Il’ichev AL, Gut LJ, Williams DG, Hossain MS, Jerie PH (2002). Area-
wide approach for improved control of oriental fruit moth Grapholita 
molesta (Busck) (Lepidoptera: Tortricidae) by mating disruption. Gen. 
Appl. Entomol. 31:7-15. 
Jackson M, Mantsch HH (1991). Protein secondary structure from FT IR 
spectroscopy with dihedral angles from three-dimensional 
Ramachandran plots. J. Chem. 69:1639-1643. 
Jiang M, Xie MX, Zheng D, Liu Y, Li XY, Chen X (2004). Spectroscopic 
studies on the interaction of cinnamic acid and its hydroxyl 
derivatives with human serum albumin. J. Mol Structure. 692:71-80. 
Kandagal PB, Shaikh SMT, ManjunathaDH, Seetharamappa J, 
Nagaralli BS (2007). Spectroscopic studies on the binding of 
bioactive phenothiazine compounds to human serum albumin. J. 
Photochem. Photobiol. A-Chem. 189(1):121-127. 
Kang J, Liu Y, Xie MX, Li S, Jiang M, Wang YD (2004). Interactions of 
human serum albumin with chlorogenic acid and ferulic acid. 
Biochimica et Biophysica Acta.1674:205-214. 
Kang S, Wu Y, X Li (2004). Effects of statin therapy on theprogression 
of carotid atherosclerosis: a systematic review and meta-analysis. 
Atherosclerosis 177(2):433-442. 
Kim CA, Berg JM (1993). Thermodynamic beta-sheet propensities 
measured using a zinc-finger host peptide. Nature 362:267-270. 
Kragh-Hansen U (1981). Molecular aspects of ligand binding to serum 
albumin. Pharmacol. Rev. 33:17- 53. 
Krimm S, Bandekar J (1986). Vibrational spectroscopy and 
conformationof peptides, polypeptides and proteins. Adv. Protein 
Chem. 38:181-364. 
Kumar VK, Ramasamy R (2002). Spectral and normal coordinate 
analysis of 6-methoxypurine. Indian J. Pure Appl. Phys. 40:252.  
Lakowicz JR (1999). Principles of fluorescence spectroscopy. Kluwer 
Academic Publishers/Plenum Press, Dordrecht/New York. 
Lakowicz  JR,  Weber G (1973). Quenching of protein fluorescence by 
oxygen. Detection of structural fluctuations in proteins on the 
nanosecond time scale Biochemistry 12 : 4161.  
Li Y, He WY, Dong YM, Sheng F, Hu ZD (2006). Human serum albumin 
interaction with formononetin studied using fluorescence anisotropy, 
FT-IR spectroscopy and molecular modeling methods. Bioorg. Med. 
Chem. 14:1431-1436. 
Liu JQ, Tian JN, He WY, Xie JP, Hu ZD, Chen XG (2004). J. Pharm. 
Biomed. Anal. 35:671. 
Liu XP, Du YX, Sun W, Kou JP, Yu BY (2009). Study on the interaction 
of levocetirizine dihydrochloride with human serum albumin by 
molecular spectroscopy. Spectrochim. Acta Part A 74:1189. 
Liu Y, Xie MX, Kang J, Zheng D (2003). Studies on the interaction of 
total saponins of panax notoginseng and human serum albumin by 
Fourier  transform  infrared spectroscopy. Spectrochim. Acta.  Part A. 
59:2747-2758. 
Locht F, Dorcbe G, Anbert G, Boissier C, Bertrand AM, Branon J 
(1990). The penetration of ceftriaxone into human brain tissue. J. 
Antimicrob. Chemother. 26:81-86. 
Mcnamara P, TruebV, Stoeckel K (1990). Ceftriaxone binding to human 
serum albumin. Inderect displacement by probenecid and diazepam. 
ochem. Pharmacol. 40:1247-1253.  
12          J. Biophys. Struct. Biol. 
 
 
 
Muravchick S, Smith DS (1995). Parkinsonian symptoms during 
emergence from general anesthesia. Anesthesiology 82:305-307. 
Nerli B, Farruggia B, Picó G (1996). A comparative study of the binding  
characteristic of of ceftriaxone, cefoperazone and cefsulodin to  
human 
serum albumin. Biochem. Mol. Biol. Int. 40:823-831. 
Oberg KA, Ruysschaert JM, Goormaghtigh E (2004). The optimization 
of protein secondary structure determination with infrared and circular 
dichroism spectra. Eur. J. Biochem. 271:2937-2948. 
Pan J, Ye Z, Cai X, Wang L, Cao Z (2012). Biophysical study on the 
interaction of ceftriaxone sodium with bovine serum albumin using 
spectroscopic methods. J. Biochem. Mol. Toxicol. 26:487-492. 
Patrick J, Mcnamara VrenyTruebs, Klaus Stoeckel (1990). Ceftriaxone 
binding to human serum albumin indirect displacement. Biochem. 
Pharmacol. 40(6):1247-1253.  
Peters T (1985). Serum albumin. Adv. Protein Chem. 37:161-245. 
Peters T Jr. (1985). Ado. Protein Chem. 37:161-245. 
Qing Y, Xi-min Z, Xing-guo C (2011). Combined molecular docking and 
multi-spectroscopic investigation on the interaction between Eosin B 
and human serum albumin. J. Lumin. 131:880-887. 
Quaglia MG, Bossu E, Dell’Aquila C, Guidotti M (1997). Determination 
of the binding of a β2-blocker drug, frusemide and ceftriaxone to 
serum proteins by capillary zone electrophoresis. J. Pharm. Biomed. 
Analys. 15:1033-1039. 
Rabia S, Shiori T, Leonid B, Sylvie D, Yves F, Dufr E, Vasanthy N, Erik 
G, Jean-Marie R, Vincent R (2009). Antiparallel β-sheet: a signature 
structure of the oligomeric amyloid β-peptide Emilie CERF. Biochem. 
J. 421:415-423. 
Reynold Spector (1987). Ceftriaxone transport through the blood-brain 
barrier. J. Infect. Dis. 156(1):209-211.  
Rondeau P, Armenta S, Caillens H, Chesne S, Bourdon E (2007). 
Assessment of temperature effects on b-aggregation of native and 
glycated albumin by FTIR spectroscopy and PAGE: Relations 
between structural changes and antioxidant properties. Archives 
Biochem. Biophys. 460:141-150. 
Royer CA (1995). Approaches to teaching fluorescence spectroscopy. 
Biophys. J. 68:1191-1195. 
Scott VM, William AP Jr, Kristin KJ, Lori K, Joseph AP (2008). Safety of 
ceftriaxone sodium at extremes of age. Expert Opin. Drug Saf. 
7(5):515-523. 
Simard AR, Soulet D, Gowing G, Julien JP, Rivest S (2006). Bone 
marrow-derived microglia play a critical role in restricting senile 
plaque formation in alzheimer’s disease. Neuron 49:489-502. 
Sirotkin VA, Zinatullin AN, Solomonov BN, Faizullin DA, Fedotov VD 
(2001). Calorimetric and Fourier transform infrared spectroscopic 
study of solid proteins immersed in low water organic solvents. 
Biochimica et Biophysica Acta. 1547:359-369. 
Sudip Bhattacharyya, Tod ES, Jean H, Swank, Craig BMarkwardt 
(2006). RXTEObservationsof1A1744361: correlated spectral and 
timing behavior. Astrophys. J. 652:603-609.  
Sulkowska A (2002). Interaction of drugs with bovine and human serum 
albumin. J. Mol. Struct. 614:227-232. 
Surewicz WK, Mantsch HH, Chapman D (1993). Determination of 
protein secondary structure by Fourier transform infrared 
spectroscopy: A critical assessment. Biochemistry 32:389-394. 
Surewicz WK, Moscarello MA, Mantsch HH (1987). Secondary structure 
of the hydrophobic myelin protein in a lipid environment as 
determined by Fourier- transform infrared spectrometry. J. Biol. 
Chem. 262:8598-8609. 
Tian JN, Liu JQ, Zhang JY, Hu ZD, Chen XG (2003). Chem. Pharm. 
Bull. 51:579. 
Ulrich H, Cleber AT, Arthur AN 2006). DNA and RNA apta-mers: from 
tools for basic research towards therapeutic applications. Comb. 
Chem. High Throughput Screen 9:619-32.  
Vandenbussche G, Clercx A, Curstedt T, Johansson J, Jornvall H, 
Ruysschaert  JM  (1992). Structure  and orientation of  the  surfactant  
associated protein C in a lipid bilayer. Eur. J. Biochem. 203:201-209. 
Vass E, Holly S, Majer Z, Samu J, Laczko I, Hollosi M (1997). FTIR and 
CD spectroscopic detection of H-bonded folded polypeptide 
structures. J. Mol. Struct. 408/409:47-56. 
 
 
 
 
 
 
Wang C, Wu Q, Li C, Wang Z, Ma J, Zang X, Qin N (2007). Interaction 
of tetrandrine with human serum albumin: a Fluorescence quenching 
study. Analyt. Sci. 23:429-433. 
Wang T, Xiang B, Wang Y, Chen C, Dong Y, Fang H, Wang M (2008). 
Spectroscopic investigation on the binding of bioactive pyridazinone  
derivative to human serum albumin and molecular modeling. Colloids 
Surf. B. 65:113-119. 
Workman JR (1998). Applied Spectroscopy: Optical Spectrometers, 
Academic Press, San Diego. pp. 21-53. 
Yue Q,  Shen T, Wang C, Gao C,  Liu J (2012). Study of the interaction 
of bovine serum albumin with ceftriaxone and the inhibition effect of 
Zinc (II). Int. J. Spectrosc. Article ID 284173, doi: 
10.1155/2012/284173. 
Zhang FL, Jespersen KG, Bjorstrom C, Svensson M, Andersson MR, 
Sundstrom V, Magnusson K, Moons E, Yartsev A, Inganas O (2006). 
Influence of guest solvents on the morphology and performance of 
solar cells based on polyfluorene copolymer/fullerene blends. Adv. 
Funct. Mater. 16:667-674 
 
 
 
